Insider Trading History of Schwabe Stefan K.f.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Schwabe Stefan K.f. since year 2005. The trader's CIK number is 1557657. At the time of the last reporting, Schwabe Stefan K.f. was the Executive Vice President R&D of Supernus Pharmaceuticals Inc . (stock ticker symbol SUPN). See this page for all insider trading activities at Supernus Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Schwabe Stefan K.f. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-06-18 SUPN Supernus Pharmaceuticals Inc Sale 60,000 54.39 3,263,340
2018-06-18 SUPN Supernus Pharmaceuticals Inc Option Ex 60,000 8.57 514,200
2017-09-07 SUPN Supernus Pharmaceuticals Inc Sale 95,000 46.59 4,425,575
2017-09-07 SUPN Supernus Pharmaceuticals Inc Option Ex 95,000 12.92 1,227,400
2015-07-28 SUPN Supernus Pharmaceuticals Inc Sale 2,350 21.20 49,831
2015-07-13 SUPN Supernus Pharmaceuticals Inc Sale 1,950 19.23 37,498
2015-06-12 SUPN Supernus Pharmaceuticals Inc Sale 2,051 18.27 37,471
2015-06-11 SUPN Supernus Pharmaceuticals Inc Sale 3,631 16.38 59,464

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schwabe Stefan K.f. (Executive Vice President R&D of Supernus Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month